Previous studies are consistent with our data, in which clinical assays have shown changes in the balance of pro- and anti-inflammatory cytokines in patients with MDD without pharmacological treatment [21] and lower IFN-γ and IL-2 levels [52]. The gene discussed is IL2; the disease is major depressive disorder.